Investors Research Corp - DIPLOMAT PHARMACY INC ownership

DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 3 filers reported holding DIPLOMAT PHARMACY INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Investors Research Corp ownership history of DIPLOMAT PHARMACY INC
ValueSharesWeighting
Q4 2019$352,000
-18.7%
87,977
-0.4%
0.16%
-26.4%
Q3 2019$433,000
-20.7%
88,327
-1.6%
0.22%
-22.8%
Q2 2019$546,000
+2.8%
89,727
-1.8%
0.28%
+0.7%
Q1 2019$531,000
-57.1%
91,327
-0.8%
0.28%
-67.3%
Q4 2018$1,239,000
-30.6%
92,0270.0%0.86%
-15.3%
Q3 2018$1,786,000
-26.6%
92,027
-3.3%
1.02%
-27.6%
Q2 2018$2,432,000
+28.5%
95,150
+1.3%
1.41%
+22.6%
Q1 2018$1,893,000
-2.3%
93,950
-2.7%
1.15%
-4.0%
Q4 2017$1,938,00096,5501.20%
Other shareholders
DIPLOMAT PHARMACY INC shareholders Q1 2020
NameSharesValueWeighting ↓
Empirical Capital Management, LLC 479,018$9,298,0008.38%
Rhenman & Partners Asset Management AB 1,174,411$22,795,0002.28%
Capital Investment Advisory Services, LLC 153,842$2,986,0001.40%
Cortina Asset Management, LLC 1,238,420$24,038,0001.12%
Investors Research Corp 92,027$1,786,0001.02%
Matarin Capital Management, LLC 697,387$13,536,282,0000.87%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 853,687$16,570,0000.59%
RICE HALL JAMES & ASSOCIATES, LLC 809,257$15,708,0000.56%
BROADVIEW ADVISORS LLC 156,700$3,042,0000.52%
FRONTIER CAPITAL MANAGEMENT CO LLC 3,535,217$68,619,0000.44%
View complete list of DIPLOMAT PHARMACY INC shareholders